Cover Image

Sexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X‐Linked Adrenoleukodystrophy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Stephanie I. W. van de Stadt, Aimy M. A. Wessel, Mirjam Langeveld, Marc Engelen, Barbara Sjouke
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Journal of Inherited Metabolic Disease
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An Automated Analysis Tool for Diffusion Tensor Imaging‐Based Quantitative MRI in X‐Linked Adrenoleukodystrophy
by: Eda G. Kabak, et al.
Published: (2025)

Progression of Spinal Cord Disease in Adult Men With Adrenoleukodystrophy
by: Hemmo A. F. Yska, et al.
Published: (2025)

The Grey Zone Project: Risk‐Based Classification of ABCD1 Variants in X‐Linked Adrenoleukodystrophy
by: Troy C. Lund, et al.
Published: (2026)

Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X‐Linked Adrenoleukodystrophy
by: Julia Lier, et al.
Published: (2026)

Myopathic Symptoms and Exercise Tolerance in Adolescent Patients With Long‐Chain Fatty Acid Oxidation Disorders
by: Marit Schwantje, et al.
Published: (2025)

Screening Tool Improves Recognition of Movement Disorders by Internists and Paediatricians in Patients With Inherited Metabolic Diseases
by: Ellen M. Hulshof, et al.
Published: (2025)

Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria
by: Eline C. B. Eskes, et al.
Published: (2024)

Medicine Development and Access for Rare Diseases: Can We Do Better?
by: Carla E. M. Hollak, et al.
Published: (2026)

Altered lipid profile and reduced neuronal support in human induced pluripotent stem cell‐derived astrocytes from adrenoleukodystrophy patients
by: Roberto Montoro Ferrer, et al.
Published: (2024)

Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies
by: M. I. Mendes, et al.
Published: (2026)

Pregnancies in Women With Long‐Chain Fatty Acid Oxidation Disorders: Results of a European and North American Survey
by: Sarah C. Grünert, et al.
Published: (2026)

Positive Clinical, Neuropsychological, and Metabolic Impact of Liver Transplantation in Patients With Argininosuccinate Lyase Deficiency
by: Barbara Siri, et al.
Published: (2025)

Impaired Proteostasis is Linked to Neurological Pathology in a Zebrafish NGLY1 Deficiency Model
by: Aviv Mesika, et al.
Published: (2025)

Cluster of Severe Arginase 1 Deficiency in the Comoros: Clinical, Neuroimaging, and Molecular Features in 17 Patients From Mayotte Compared With 10 From Paris
by: Aurélie De Bruyne, et al.
Published: (2026)

Never‐Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow‐Up
by: Alberto Nasce, et al.
Published: (2025)

Quo vadis ureagenesis disorders? A journey from 90 years ago into the future
by: Johannes Häberle, et al.
Published: (2024)

Brain Age in Adult Patients With Early‐Treated Phenylketonuria
by: Laura Winiger, et al.
Published: (2026)

Molecular Profile of Mucopolysaccharidosis Type I Patients in Brazil
by: Carlos Robson Costa Cruz, et al.
Published: (2026)

Long‐Term Follow‐Up of Patients With Transaldolase Deficiency
by: Marco Scaglione, et al.
Published: (2026)

Outcome of Haemopoietic Stem Cell Transplantation in 21 Patients With Alpha‐Mannosidosis
by: Robert Šáhó, et al.
Published: (2025)

Real‐Life Application of a Point‐of‐Care Biosensor for Phenylalanine in Patients With Phenylketonuria
by: Corentin Gondrand, et al.
Published: (2026)

Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis
by: Natalja Bouwhuis, et al.
Published: (2026)

Long‐Read Sequencing Expands the Genotypic Spectrum of Patients With Mucopolysaccharidosis Type II
by: Na Hao, et al.
Published: (2025)

Correction to “Outcome of Haemopoietic Stem Cell Transplantation in 21 Patients With Alpha‐Mannosidosis”
Published: (2025)

Long term survival in patients with classic infantile Pompe disease reveals a spectrum with progressive brain abnormalities and changes in cognitive functioning
by: J. J. A. van den Dorpel, et al.
Published: (2024)

Expression Profiles of Exosomal miRNAs in Gaucher Patients and Their Association With Severity of Bone Involvement
by: Irene Serrano‐Gonzalo, et al.
Published: (2025)

The relation between dietary polysaccharide intake and urinary excretion of tetraglucoside
by: Candelas Gross‐Valle, et al.
Published: (2024)

Increased Survival in Patients With Molybdenum Cofactor Deficiency Type A Treated With Cyclic Pyranopterin Monophosphate
by: Guenter Schwarz, et al.
Published: (2025)

The Current Status of Adult Patients With Urea Cycle Disorders in Japan: From the Nation‐Wide Study
by: Jun Kido, et al.
Published: (2025)

Setting the Stage for Treatment of Aminoacyl‐ tRNA Synthetase ( ARS )1‐Deficiencies: Phenotypic Characterization and a Review of Treatment Effects
by: Eva M. M. Hoytema van Konijnenburg, et al.
Published: (2025)

Correction to “Clinical Outcomes in Patients Switching From Agalsidase Beta to Migalastat: A Fabry Registry Analysis”
Published: (2025)

Intra‐ and extracellular real‐time analysis of perfused fibroblasts using an NMR bioreactor: A pilot study
by: Christian Urzì, et al.
Published: (2024)

Impact of Early Intervention on the Developmental and Ocular Outcome of Patients With Cobalamin C Deficiency Identified Through Newborn Screening
by: Anna T. Reischl‐Hajiabadi, et al.
Published: (2026)

Allopurinol Treatment Improves Cognitive Skills, Adaptive Behavior, and Biochemical Markers in Young Patients With Adenylosuccinate Lyase Deficiency
by: Bérangère Rousselot‐Pailley, et al.
Published: (2025)

Reversible white matter changes following a 4‐week high phenylalanine exposure in adults with phenylketonuria
by: Raphaela Muri, et al.
Published: (2024)

Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU‐MOMs sub‐registries
by: François Feillet, et al.
Published: (2024)

The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!
by: Bibiche den Hollander, et al.
Published: (2025)

The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuria
by: A. M. J. van Wegberg, et al.
Published: (2024)

Longitudinal volumetric analysis of gray matter atrophy in metachromatic leukodystrophy
by: Murtadha L. Al‐Saady, et al.
Published: (2024)

Disease Burden and Pharmacological Treatment Patterns in Children and Adults With Phenylketonuria: A Real‐World Matched Cohort Study
by: Nicola Longo, et al.
Published: (2026)